Labcorp Holdings Inc. (LH) Stock

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Labcorp Holdings Inc. is led by CEO Adam H. Schechter, employs 71,000 people, headquartered in Burlington, US, publicly traded since 1990.

Labcorp Holdings Inc. (LH) stock trades at $314.14 with a market capitalization of $25.76B. The stock is valued at a price-to-earnings (P/E) ratio of 24.43, price-to-book of 2.43, price-to-sales of 1.49. Over the past 52 weeks the stock has ranged between $241.81 and $314.14, and currently trades at its 52-week high. It pays a dividend yielding 1.12%.

On profitability, Labcorp Holdings Inc. generates a return on equity (ROE) of 10.17%, return on capital employed of 17.55%, an operating margin of 10.87%, a net profit margin of 6.66%.

In its most recent fiscal year, Labcorp Holdings Inc. reported annual revenue of $14.0B, net profit of $877.0M, revenue has compounded at -0.0% a year over the last five years, profit at -10.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.83, a current ratio of 1.42, total assets of $18.4B, $532.0M in cash and equivalents.

LH has an average daily trading volume of 697,345 shares, a beta of 0.88.

Official website: www.labcorp.com